Psychometric Properties of the revised piper fatigue scale in Greek women with breast cancer
Date Issued
2001
Abstract
The aim of this research was the assessment of reliability, validity and responsiveness of the Revised Piper
Fatigue Scale (RPFS) in Greek women with breast cancer. A total number of 174 cancer patients were interviewed
and completed the RPFS. The mean age of the sample was 56.5±12.2 years old. Factor analysis confirmed the
multidimensionality of the RPFS, associated with 4 factors/subscales. The RPFS has a high internal consistency
(Cronbach’s a= 0,91). The mean fatigue score is independent of the place of permanent residence (p=0.14), and the
occupation (p=0.26). There is no statistically significant difference of the scores among the education levels (p=0.23)
and among the marital status (p=0.47). There is a weak linear relation (r=0.116) between the overall score and the
age. There is also a strong linear relation between the fatigue score and the Langer score (r=0.76). Future research
plans could include the comparison of the various breast cancer therapies in terms of the fatigue level and the
investigation of whether the same scale applies for other type of cancer.
Fatigue Scale (RPFS) in Greek women with breast cancer. A total number of 174 cancer patients were interviewed
and completed the RPFS. The mean age of the sample was 56.5±12.2 years old. Factor analysis confirmed the
multidimensionality of the RPFS, associated with 4 factors/subscales. The RPFS has a high internal consistency
(Cronbach’s a= 0,91). The mean fatigue score is independent of the place of permanent residence (p=0.14), and the
occupation (p=0.26). There is no statistically significant difference of the scores among the education levels (p=0.23)
and among the marital status (p=0.47). There is a weak linear relation (r=0.116) between the overall score and the
age. There is also a strong linear relation between the fatigue score and the Langer score (r=0.76). Future research
plans could include the comparison of the various breast cancer therapies in terms of the fatigue level and the
investigation of whether the same scale applies for other type of cancer.